$HAE
HAEMONETICS CORP

2012 Q4 Form 10-Q Financial Statement

#000031314313000023 Filed on February 01, 2013

View on sec.gov

Income Statement

Concept 2012 Q4 2011 Q4
Revenue $247.4M $191.2M
YoY Change 29.42% 14.58%
Cost Of Revenue $134.3M $95.23M
YoY Change 41.01% 20.42%
Gross Profit $113.1M $95.93M
YoY Change 17.91% 9.32%
Gross Profit Margin 45.72% 50.18%
Selling, General & Admin $86.78M $61.38M
YoY Change 41.39% 16.26%
% of Gross Profit 76.72% 63.98%
Research & Development $10.59M $9.232M
YoY Change 14.69% 16.07%
% of Gross Profit 9.36% 9.62%
Depreciation & Amortization $18.10M $12.60M
YoY Change 43.65% 2.44%
% of Gross Profit 16.0% 13.13%
Operating Expenses $97.37M $70.61M
YoY Change 37.9% 19.98%
Operating Profit $15.75M $25.32M
YoY Change -37.82% -12.39%
Interest Expense -$2.500M $400.0K
YoY Change -725.0% 1639.13%
% of Operating Profit -15.88% 1.58%
Other Income/Expense, Net -$2.542M $140.0K
YoY Change -1915.71% -164.81%
Pretax Income $13.21M $25.46M
YoY Change -48.14% -12.68%
Income Tax $3.301M $7.211M
% Of Pretax Income 25.0% 28.32%
Net Earnings $9.904M $13.88M
YoY Change -28.65% -34.95%
Net Earnings / Revenue 4.0% 7.26%
Basic Earnings Per Share $0.19 $0.27
Diluted Earnings Per Share $0.19 $0.27
COMMON SHARES
Basic Shares Outstanding 51.71M shares 50.15M shares
Diluted Shares Outstanding 52.61M shares 50.88M shares

Balance Sheet

Concept 2012 Q4 2011 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $193.2M $183.4M
YoY Change 5.34% 59.48%
Cash & Equivalents $193.2M $205.4M
Short-Term Investments
Other Short-Term Assets $58.30M $27.00M
YoY Change 115.93% 5.81%
Inventory $180.0M $107.9M
Prepaid Expenses
Receivables $167.3M $127.4M
Other Receivables $0.00 $0.00
Total Short-Term Assets $598.9M $467.2M
YoY Change 28.19% 28.97%
LONG-TERM ASSETS
Property, Plant & Equipment $263.1M $157.7M
YoY Change 66.85% 0.26%
Goodwill $321.3M $115.3M
YoY Change 178.6% 2.61%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $16.65M $9.760M
YoY Change 70.6% -1.6%
Total Long-Term Assets $875.5M $380.6M
YoY Change 130.03% 1.35%
TOTAL ASSETS
Total Short-Term Assets $598.9M $467.2M
Total Long-Term Assets $875.5M $380.6M
Total Assets $1.474B $847.8M
YoY Change 73.91% 14.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $53.08M $28.89M
YoY Change 83.71% 33.58%
Accrued Expenses $40.90M $26.80M
YoY Change 52.61% -11.55%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $14.20M $2.545M
YoY Change 457.84% -78.25%
Total Short-Term Liabilities $177.6M $109.4M
YoY Change 62.4% -3.85%
LONG-TERM LIABILITIES
Long-Term Debt $468.3M $3.107M
YoY Change 14970.81% -29.75%
Other Long-Term Liabilities $23.86M $13.29M
YoY Change 79.52% 6.41%
Total Long-Term Liabilities $492.1M $16.40M
YoY Change 2901.21% -3.05%
TOTAL LIABILITIES
Total Short-Term Liabilities $177.6M $109.4M
Total Long-Term Liabilities $492.1M $16.40M
Total Liabilities $669.7M $125.8M
YoY Change 432.52% -3.75%
SHAREHOLDERS EQUITY
Retained Earnings $409.6M $383.0M
YoY Change 6.94% 15.04%
Common Stock $362.7M $313.1M
YoY Change 15.83% 22.17%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $779.2M $705.2M
YoY Change
Total Liabilities & Shareholders Equity $1.474B $847.8M
YoY Change 73.91% 14.92%

Cashflow Statement

Concept 2012 Q4 2011 Q4
OPERATING ACTIVITIES
Net Income $9.904M $13.88M
YoY Change -28.65% -34.95%
Depreciation, Depletion And Amortization $18.10M $12.60M
YoY Change 43.65% 2.44%
Cash From Operating Activities $23.90M $25.40M
YoY Change -5.91% -17.53%
INVESTING ACTIVITIES
Capital Expenditures -$15.30M -$12.00M
YoY Change 27.5% 34.83%
Acquisitions
YoY Change
Other Investing Activities $900.0K $100.0K
YoY Change 800.0% -50.0%
Cash From Investing Activities -$14.30M -$11.90M
YoY Change 20.17% 36.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -3.800M -46.30M
YoY Change -91.79% -709.21%
NET CHANGE
Cash From Operating Activities 23.90M 25.40M
Cash From Investing Activities -14.30M -11.90M
Cash From Financing Activities -3.800M -46.30M
Net Change In Cash 5.800M -32.80M
YoY Change -117.68% -210.44%
FREE CASH FLOW
Cash From Operating Activities $23.90M $25.40M
Capital Expenditures -$15.30M -$12.00M
Free Cash Flow $39.20M $37.40M
YoY Change 4.81% -5.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
35425000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
53077000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
167347000 USD
CY2012Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
135464000 USD
CY2012Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
8075000 USD
CY2012Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
6632000 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
356373000 USD
CY2012Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
348877000 USD
CY2012Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
9110000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
6890000 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
362199000 USD
CY2012Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
322232000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6700000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7900000 USD
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1715000 USD
CY2012Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1480000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1200000 shares
CY2012Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
700000 shares
CY2011Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1800000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
400000 shares
CY2012Q4 us-gaap Assets
Assets
1474373000 USD
CY2012Q1 us-gaap Assets
Assets
911135000 USD
CY2012Q1 us-gaap Assets Current
AssetsCurrent
527129000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
598882000 USD
CY2012Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
146823000 USD
CY2012Q4 us-gaap Average Remaining Maturity Of Foreign Currency Derivatives1
AverageRemainingMaturityOfForeignCurrencyDerivatives1
P1Y
us-gaap Basis Of Accounting
BasisOfAccounting
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">BASIS OF PRESENTATION</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles (&#8220;GAAP&#8221;) in the United States for interim financial information and with the instructions to Form 10-Q and Article&#160;10 of Regulation&#160;S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of our management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. All significant intercompany transactions have been eliminated. Operating results for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">nine</font><font style="font-family:inherit;font-size:10pt;"> month period ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;29, 2012</font><font style="font-family:inherit;font-size:10pt;"> are not necessarily indicative of the results that may be expected for the full fiscal year ending </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;30, 2013</font><font style="font-family:inherit;font-size:10pt;">, or any other interim period. These unaudited consolidated financial statements should be read in conjunction with our audited consolidated financial statements and footnotes included in our annual report on Form 10-K for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2012</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure. Subsequent events have been evaluated, and these financial statements reflect those material items that arose after the balance sheet date but prior to the issuance of the financial statements that would be considered recognized subsequent events. There were no material recognized subsequent events recorded in the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;29, 2012</font><font style="font-family:inherit;font-size:10pt;"> consolidated financial statements.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our fiscal year ends on the Saturday closest to the last day of March. Fiscal years </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2012</font><font style="font-family:inherit;font-size:10pt;"> include </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">52</font><font style="font-family:inherit;font-size:10pt;">&#160;weeks with each quarter having </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">13</font><font style="font-family:inherit;font-size:10pt;">&#160;weeks.</font></div></div>
CY2011Q4 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability
0 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability
0 USD
CY2012Q4 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability
0 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability
1580000 USD
CY2011Q4 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
15400000 USD
CY2012Q4 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
18400000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
228861000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
193181000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
205372000 USD
CY2011Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
196707000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
8665000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-35680000 USD
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2012Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50603798 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51638739 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51638739 shares
CY2012Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50603798 shares
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
516000 USD
CY2012Q1 us-gaap Common Stock Value
CommonStockValue
506000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
48657000 USD
CY2012Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
12239000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
24020000 USD
CY2011Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
18585000 USD
CY2012Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
134280000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
337058000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
266545000 USD
CY2011Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
95229000 USD
us-gaap Debt Instrument Description Of Variable Rate Basis
DebtInstrumentDescriptionOfVariableRateBasis
LIBOR
CY2012Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
10807000 USD
CY2012Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
9665000 USD
CY2012Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
23000 USD
CY2012Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
733000 USD
CY2012Q1 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
64000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
250000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
25497000 USD
CY2012Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
23332000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
37256000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
46741000 USD
CY2012Q1 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
6186000 USD
CY2012Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
3904000 USD
CY2012Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
2270000 USD
CY2012Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
1185000000 USD
CY2012Q4 us-gaap Derivative Financial Instruments Liabilities Fair Value Disclosure
DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure
927000 USD
CY2011Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.51
CY2012Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.97
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.95
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.50
CY2012Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2011Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
289000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-522000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.255
CY2012Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.250
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
40897000 USD
CY2012Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
29451000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2500000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2000000 USD
us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
4142000 USD
us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
3722000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
839000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
3158000 USD
CY2012Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
54973000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
71102000 USD
CY2012Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
96549000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
273695000 USD
CY2012Q4 us-gaap Foreign Currency Cash Flow Hedge Derivative At Fair Value Net
ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet
133400000 USD
CY2012Q1 us-gaap Foreign Currency Cash Flow Hedge Derivative At Fair Value Net
ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet
162100000 USD
CY2012Q4 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
3904000 USD
CY2012Q4 us-gaap Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
1343000 USD
CY2012Q4 us-gaap Foreign Currency Derivative Instruments Not Designated As Hedging Instruments At Fair Value Net
ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet
68900000 USD
CY2012Q1 us-gaap Foreign Currency Derivative Instruments Not Designated As Hedging Instruments At Fair Value Net
ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet
45500000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-472000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-280000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
321284000 USD
CY2012Q1 us-gaap Goodwill
Goodwill
115058000 USD
us-gaap Gross Profit
GrossProfit
274629000 USD
CY2011Q4 us-gaap Gross Profit
GrossProfit
95931000 USD
CY2012Q4 us-gaap Gross Profit
GrossProfit
113115000 USD
us-gaap Gross Profit
GrossProfit
304990000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
35211000 USD
CY2012Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
13205000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
68168000 USD
CY2011Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
25463000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19088000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8972000 USD
CY2012Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3301000 USD
CY2011Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7211000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6098000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
8900000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2188000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
22686000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
32165000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1461000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12732000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
23047000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
874000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
4489000 USD
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-14949000 USD
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
1673000 USD
us-gaap Interest Paid Net
InterestPaidNet
322000 USD
us-gaap Interest Paid Net
InterestPaidNet
4020000 USD
CY2012Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
112550000 USD
CY2012Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
71304000 USD
CY2012Q1 us-gaap Inventory Net
InventoryNet
117163000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
180037000 USD
CY2012Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
41219000 USD
CY2012Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
58508000 USD
CY2012Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
8979000 USD
CY2012Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
4640000 USD
CY2012Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
142919000 USD
CY2012Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
14197000 USD
CY2012Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
894000 USD
CY2012Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2877000 USD
CY2012Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
911135000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1474373000 USD
CY2012Q1 us-gaap Liabilities Current
LiabilitiesCurrent
130744000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
177610000 USD
CY2012Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
2270000 USD
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
468250000 USD
CY2012Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
196869000 USD
CY2012Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
136057000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
491038000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-35714000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-36442000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-584539000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
81343000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
57532000 USD
CY2011Q4 us-gaap Net Income Loss
NetIncomeLoss
18252000 USD
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
9904000 USD
us-gaap Net Income Loss
NetIncomeLoss
26239000 USD
us-gaap Net Income Loss
NetIncomeLoss
49080000 USD
us-gaap Operating Expenses
OperatingExpenses
206831000 USD
CY2011Q4 us-gaap Operating Expenses
OperatingExpenses
70608000 USD
us-gaap Operating Expenses
OperatingExpenses
266261000 USD
CY2012Q4 us-gaap Operating Expenses
OperatingExpenses
97368000 USD
CY2012Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
15747000 USD
CY2011Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
25323000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
38729000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
67798000 USD
CY2012Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10719000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
16651000 USD
CY2012Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
62557000 USD
CY2012Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
56835000 USD
CY2012Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
21551000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
23858000 USD
CY2011Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
140000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
370000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3518000 USD
CY2012Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2542000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
49998000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
18042000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
5461000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Payments To Acquire Business Two Net Of Cash Acquired
PaymentsToAcquireBusinessTwoNetOfCashAcquired
0 USD
us-gaap Payments To Acquire Business Two Net Of Cash Acquired
PaymentsToAcquireBusinessTwoNetOfCashAcquired
1000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
535144000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
49685000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
36959000 USD
CY2012Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
35976000 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
47510000 USD
CY2011Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1273000 USD
CY2012Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
604000 USD
CY2012Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
796000 USD
CY2011Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1490000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
1680000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
1076000 USD
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
884000 USD
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
1897000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
475000000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
4557000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
1529000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
517000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1290000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
9076000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
28342000 USD
CY2012Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
510534000 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
619501000 USD
CY2012Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
161657000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
263128000 USD
CY2012Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
241435000 USD
CY2012Q1 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
226476000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
882000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
658000 USD
CY2011Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9232000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28190000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
30823000 USD
CY2012Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10588000 USD
us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
4700000 USD
us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
4400000 USD
CY2011Q3 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
1700000 USD
us-gaap Restructuring Charges
RestructuringCharges
4859000 USD
us-gaap Restructuring Charges
RestructuringCharges
5225000 USD
CY2012Q4 us-gaap Restructuring Charges
RestructuringCharges
2900000 USD
CY2011Q2 us-gaap Restructuring Reserve
RestructuringReserve
3671000 USD
CY2011Q4 us-gaap Restructuring Reserve
RestructuringReserve
3362000 USD
CY2012Q4 us-gaap Restructuring Reserve
RestructuringReserve
2796000 USD
CY2012Q1 us-gaap Restructuring Reserve
RestructuringReserve
1994000 USD
us-gaap Restructuring Reserve Settled With Cash
RestructuringReserveSettledWithCash
5168000 USD
us-gaap Restructuring Reserve Settled With Cash
RestructuringReserveSettledWithCash
4423000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
409553000 USD
CY2012Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
400783000 USD
CY2012Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
247395000 USD
CY2011Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
191160000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
642048000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
541174000 USD
CY2012Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
86780000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
235438000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
180221000 USD
CY2011Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
61376000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
7931000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
6727000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.2694
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.2795
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0072
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0112
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.76
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.15
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y11M19D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y10M24D
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
150763 shares
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
154520 shares
CY2012Q1 us-gaap Stockholders Equity
StockholdersEquity
732631000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
779158000 USD
CY2012Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio
StockholdersEquityNoteStockSplitConversionRatio
2
us-gaap Tax Benefit From Stock Options Exercised1
TaxBenefitFromStockOptionsExercised1
3905000 USD
us-gaap Tax Benefit From Stock Options Exercised1
TaxBenefitFromStockOptionsExercised1
1410000 USD
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1365000 USD
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-617000 USD
CY2011Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
722000 shares
CY2012Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
899000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
900000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
848000 shares
CY2011Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50876000 shares
CY2012Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52606000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52264000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51666000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51364000 shares
CY2012Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51707000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50818000 shares
CY2011Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50154000 shares
CY2011Q3 hae Contingent Consideration Paid
ContingentConsiderationPaid
700000 USD
CY2012Q4 hae Land Building And Building Improvements
LandBuildingAndBuildingImprovements
80242000 USD
CY2012Q1 hae Land Building And Building Improvements
LandBuildingAndBuildingImprovements
59816000 USD
CY2012Q1 hae Total Other Assets
TotalOtherAssets
222349000 USD
CY2012Q4 hae Total Other Assets
TotalOtherAssets
612363000 USD
hae Transfers From Inventory To Fixed Assets
TransfersFromInventoryToFixedAssets
19606000 USD
hae Transfers From Inventory To Fixed Assets
TransfersFromInventoryToFixedAssets
10912000 USD
CY2012Q1 hae Office Equipment And Information Technology
OfficeEquipmentAndInformationTechnology
88185000 USD
CY2012Q4 hae Office Equipment And Information Technology
OfficeEquipmentAndInformationTechnology
100955000 USD
hae Reversal Of Interest Expense On Contingent Consideration
ReversalOfInterestExpenseOnContingentConsideration
574000 USD
hae Reversal Of Interest Expense On Contingent Consideration
ReversalOfInterestExpenseOnContingentConsideration
0 USD
hae Stock Issued During Period Employee Stock Purchase Plans Price Per Share
StockIssuedDuringPeriodEmployeeStockPurchasePlansPricePerShare
24.58
hae Stock Issued During Period Employee Stock Purchase Plans Price Per Share
StockIssuedDuringPeriodEmployeeStockPurchasePlansPricePerShare
27.47
hae Term Of Each Fiscal Quarter
TermOfEachFiscalQuarter
P1Y
CY2012 hae Term Of Each Fiscal Quarter
TermOfEachFiscalQuarter
P1Y
hae Term Of Each Quarter
TermOfEachQuarter
P3M
CY2012 hae Term Of Each Quarter
TermOfEachQuarter
P3M
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Period End Date
DocumentPeriodEndDate
2012-12-29
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000313143
CY2012Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
51638739 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
HAEMONETICS CORP

Files In Submission

Name View Source Status
0000313143-13-000023-index-headers.html Edgar Link pending
0000313143-13-000023-index.html Edgar Link pending
0000313143-13-000023.txt Edgar Link pending
0000313143-13-000023-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
hae-20121229.xml Edgar Link completed
hae-20121229.xsd Edgar Link pending
hae-20121229_cal.xml Edgar Link unprocessable
hae-20121229_def.xml Edgar Link unprocessable
hae-20121229_lab.xml Edgar Link unprocessable
hae-20121229_pre.xml Edgar Link unprocessable
hae20121229exh31.htm Edgar Link pending
hae20121229exh311.htm Edgar Link pending
hae20121229exh312.htm Edgar Link pending
hae20121229exh321.htm Edgar Link pending
hae20121229exh322.htm Edgar Link pending
hae20121229q3.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending